Auto Amazon Links: No products found. Blocked by captcha.
New research has revealed a significant disparity in head and neck cancer outcomes between the most and least socioeconomically deprived areas in the UK. Individuals living in the poorest communities not only face a higher likelihood of dying from this form of cancer but are also more often diagnosed at later stages and experience longer delays before beginning treatment compared to those in wealthier regions.
A report jointly produced by the Northern Head and Neck Alliance (NHNA) and Health Equity North emphasizes the extent of these inequalities, which persist throughout the entire cancer care pathway. The findings show that risk factors, stages at diagnosis, access to medical services, treatment adherence, and survival rates all vary markedly according to socioeconomic status. The study highlights that northern England and Scotland bear some of the greatest burdens, with these areas exhibiting particularly high rates of incidence and mortality from head and neck cancers—trends expected to escalate in the coming years.
The research team, comprising experts from Newcastle University, University of Glasgow, University of Sheffield, and University of Liverpool, alongside NHS clinicians from northern England and Scotland, analyzed existing datasets to better understand how deprivation influences cancer outcomes. Their analysis found that patients in the most deprived areas are almost two and a half times more likely to die from head and neck cancers than those in the least deprived areas. Moreover, all seven northern Integrated Care Boards recorded cancer rates exceeding the national average, with six also experiencing higher death rates. The North East and North Cumbria regions were identified as having the worst mortality rates in England, with Scotland’s figures even more concerning.
The study also uncovered additional factors linked to deprivation. Those from the poorest areas in England have a 16% higher chance of being diagnosed at an advanced disease stage. Treatment waiting times for head and neck cancer patients are among the longest in England, with nearly half failing to commence treatment within the NHS 62-day benchmark. Patients from deprived backgrounds are 33% more likely to wait over 104 days. Furthermore, uptake of the HPV vaccine, a preventative measure for some types of head and neck cancers, is 21% lower in deprived areas. Dental referrals, crucial for early detection, are also less frequent among these populations despite early visits playing a vital role in spotting symptoms.
Head and neck cancers, which include malignancies of the mouth, tongue, salivary glands, nose, throat, and voice box, profoundly affect patients’ quality of life, impacting swallowing, speech, facial appearance, taste, and the enjoyment of food. At present, approximately 13,000 new cases are diagnosed annually in the UK, resulting in 5,000 deaths each year, with projections indicating an increase to over 16,000 cases per year during the 2030s.
In response to these findings, NHNA and Health Equity North are calling for targeted interventions to address these inequities. Their recommendations urge enhancements in public health initiatives, NHS services, and research efforts. Priorities include expanding smoking cessation and alcohol reduction support in disadvantaged communities, intensifying tobacco control measures, and raising HPV vaccination rates in schools serving deprived areas. They also advocate for improved access to NHS care through better primary care and dental services, systematic monitoring of waiting time disparities, and involving local communities in service design. Furthermore, the authors stress the need for increased research funding to unravel the root causes of inequality, develop new prevention and early detection methods, establish a national cancer cohort, and broaden trial participation among underrepresented groups.
Several experts involved in the report underscored the urgency of addressing these disparities. Professor Matt Ashton, Public Health Director at Liverpool City Council, stated, “Head and neck cancer remains one of the most under-recognised and unfairly distributed cancer burdens in our communities. People in our most disadvantaged areas are facing higher risks, later diagnoses, and tougher treatment journeys than anyone should have to endure.” Similarly, Mr James O’Hara, Consultant ENT surgeon and Deputy Chair of the NHNA, emphasized that “No cancer should be more deadly because of the community you come from,” highlighting the alignment between government cancer strategies and the actions needed to close these gaps. Professor David Conway of the University of Glasgow pointed out that tackling the socioeconomic roots of health inequality is essential to improving survival rates and reducing the heavy toll of head and neck cancer in poorer communities.
Hannah Davies, Executive Director at Health Equity North, reinforced the call for urgent, decisive action. She remarked, “Where you live, how much money you have, and the challenges you face in daily life shouldn’t dictate your chances of surviving this cancer.” With incidence rates continuing to rise, addressing these long-standing inequalities is critical to transforming outcomes for affected communities across the UK
Read the full article on Liverpool Express here: Read More
Auto Amazon Links: No products found. Blocked by captcha.